Ligand Acquires Rights to More Than 15 Development Programs from Selexis SA
May 11, 2015 at 08:16 AM EDT
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has acquired a portfolio of potential future milestone and royalty payments for more ...